Related Experiment Video
Updated: Jul 17, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Percutaneous balloon mitral valvuloplasty in patients with mitral restenosis after previous surgical commissurotomy.
Insights
Balloon mitral valvuloplasty is safe and effective for treating mitral restenosis after surgery. The procedure shows similar immediate and midterm results compared to treating unoperated mitral stenosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Percutaneous balloon mitral valvuloplasty (PBMV) efficacy is established for unoperated mitral stenosis.
- Limited data exists on PBMV effectiveness for mitral restenosis post-surgical commissurotomy.
Purpose of the Study:
- To evaluate immediate and midterm outcomes of PBMV in patients with mitral restenosis after prior surgery.
- To compare these outcomes with PBMV in patients with unoperated mitral stenosis.
Main Methods:
- 29 patients with mitral restenosis (group 1) underwent Inoue PBMV.
- Matched comparison with 29 patients with unoperated mitral stenosis (group 2).
- Evaluated baseline echocardiographic scores, mitral valve area, and regurgitation severity.
Main Results:
- PBMV achieved identical improvements in transmitral gradient and mitral valve area (0.8 to 1.6 cm2) in both groups.
- Similar changes in mitral regurgitation severity were observed.
- Successful procedures with no major complications; 17% restenosis rate at follow-up, similar between groups.
Conclusions:
- PBMV is safe and effective for selected patients with mitral restenosis post-commissurotomy.
- Outcomes are comparable to those in patients with de novo mitral stenosis.
Background:
Although the efficacy of percutaneous balloon mitral valvuloplasty in patients with unoperated mitral stenosis has been well documented, there exists less clear-cut data on its effectiveness in patients with mitral restenosis after previous surgical commissurotomy. Accordingly, the purpose of this study was to evaluate our immediate and midterm results of balloon mitral valvuloplasty in this subset of patients with previous mitral surgery.
Methods:
Between October 1991 and August 1995, 29 consecutive patients with mitral restenosis after prior surgical commissurotomy (group 1) underwent Inoue balloon mitral valvuloplasty. They were matched on a patient-to-patient basis with regard to baseline mitral echocardiographic score mitral valve area, severity of angiographic mitral regurgitation and follow-up duration with 29 other patients with unoperated mitral stenosis (group 2) who underwent balloon mitral valvuloplasty during the same study period.
Results:
Balloon mitral valvuloplasty yielded identical improvements in transmitral gradient and mitral valve area (from 0.8 to 1.6 cm2) determined echocardiographically, and similar changes in the severity of mitral regurgitation in both groups of patients. All procedures were successfully completed without major cardiac complications. Follow-up echocardiographic assessment in 73% of patients revealed equal mitral valve area (1.6 cm2) and a restenosis rate of 17%, with no difference in the restenosis rate between the two groups.
Conclusion:
Balloon mitral valvuloplasty in selected patients with mitral restenosis after past surgical commissurotomy can be performed safely and with similar immediate and midterm efficacy as in patients with de novo mitral stenosis.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management

